Abcellera Biologics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Abcellera Biologics
Tip: Access up to 7 years of quarterly data
All positions including Abcellera Biologics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Abcellera Biologics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $7.8M | 2.2M | 3.49 |
| 2025-12-31 | $10M | 3.0M | 3.42 |
| 2025-09-30 | $14M | 2.8M | 5.03 |
| 2025-06-30 | $3.4M | 997k | 3.43 |
| 2024-12-31 | $2.7M | 937k | 2.93 |
| 2024-09-30 | $1.5M | 590k | 2.60 |
| 2024-06-30 | $1.6M | 552k | 2.96 |
| 2024-03-31 | $1.8M | 390k | 4.53 |
| 2023-12-31 | $2.2M | 377k | 5.71 |
| 2023-09-30 | $2.7M | 581k | 4.60 |
| 2023-06-30 | $7.6M | 1.2M | 6.46 |
| 2022-12-31 | $6.4M | 636k | 10.13 |
| 2022-06-30 | $5.1M | 479k | 10.64 |
| 2022-03-31 | $3.8M | 393k | 9.73 |
| 2021-06-30 | $12M | 574k | 21.59 |
| 2020-12-31 | $118k | 3.0k | 40.00 |